undamentalytics Newsletter

Lacarte John J: insider trades

Director at CB Financial Services, Inc. 20 open-market purchases and 2 sales not made under a pre-set plan, reported from February 5, 2015 to July 31, 2025.

Would copying Lacarte John J’s purchases have beaten the S&P 500?

Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on February 6, 2015 into $21,343 by November 2, 2026, +6.7% a year. The copy held shares only 67% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $37,779, +12.0% a year (the S&P 500 held throughout made $44,666, +13.6% a year). Beta against the index was 0.21. Twelve months after each report, the average purchase was −6.9% against the S&P 500 (median −5.5%), and 30% beat it: within what luck alone would produce (p = 0.80 over 7 years). Measured from the trade date, the insider’s own timing, the average was −7.0%. After their sales, the shares moved +1.8% against the index over 12 months on average (a negative figure means selling was the right call); 50% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 201520172019202120232025 $44.7k$37.8k$21.3k
Copying Lacarte John JS&P 500, same days investedS&P 500, held throughout $10,000 copying Lacarte John J’s open-market purchases from February 6, 2015, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+6.7%
S&P 500, same days invested
+12.0% (held throughout +13.6%)
Time in shares
67%
Sharpe ratio (S&P 500)
0.30 (0.69)
Biggest drop (S&P 500)
−51% (−34%)
Market sensitivity (beta)
0.21
Purchases copied
20

Trade by trade

Lacarte John J: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 20 +2.1% +5.1% 65% 7 2.15 0.075 No reliable evidence
Purchases, 6 months after the report 20 −0.8% +1.1% 55% 7 0.76 0.48 No reliable evidence
Purchases, 12 months after the report 20 −6.9% −5.5% 30% 7 −0.26 0.80 No reliable evidence
Purchases, 12 months after the trade 20 −7.0% −2.2% 45% 7 −0.24 0.82 No reliable evidence
Sales, 3 months after the report 2 −4.0% −4.0% 100% 2 — — Not enough years
Sales, 12 months after the report 2 +1.8% +1.8% 50% 2 — — Not enough years
Sales, 12 months after the trade 2 −4.7% −4.7% 100% 2 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
CB Financial Services, Inc. CBFV —202February 5, 2015July 31, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
July 31, 2025July 30, 2025 CBFV Sale $21,077 −4.7%−1.6%−4.5%
December 11, 2024December 9, 2024 CBFV Sale $23,852 −3.3%+5.2%−4.9%
June 6, 2023June 5, 2023 CBFV Purchase $144,760 +0.5%−9.2%+0.4%
December 15, 2020December 11, 2020 CBFV Purchase $19,773 +15.7%−5.8%−10.9%
September 23, 2020September 21, 2020 CBFV Purchase $451,245 −1.6%−5.2%−8.0%
September 4, 2020September 2, 2020 CBFV Purchase $109,678 +5.2%−9.9%−4.4%
August 24, 2020August 20, 2020 CBFV Purchase $428,875 +19.0%−0.1%+3.0%
May 15, 2020May 13, 2020 CBFV Purchase $53,400 −34.3%−42.2%−44.3%
November 25, 2019November 22, 2019 CBFV Purchase $32,152 +5.9%−36.8%−34.9%
September 23, 2019September 20, 2019 CBFV Purchase $12,210 +4.9%−39.5%−39.7%
August 1, 2019July 31, 2019 CBFV Purchase $47,500 +7.9%−39.9%−41.2%
March 15, 2019March 14, 2019 CBFV Purchase $74,970 −8.0%−3.7%−0.1%
December 19, 2018December 18, 2018 CBFV Purchase $56,812 −14.9%−2.0%+1.5%
November 2, 2018November 2, 2018 CBFV Purchase $34,927 −10.1%−13.1%−12.9%
February 22, 2018February 21, 2018 CBFV Purchase $27,072 +14.9%−13.6%−15.4%
February 21, 2018February 20, 2018 CBFV Purchase $15,827 +13.5%−16.6%−15.2%
May 31, 2017May 30, 2017 CBFV Purchase $10,556 +9.6%+29.1%+20.6%
May 24, 2017May 22, 2017 CBFV Purchase $11,850 +7.2%+21.8%+14.8%
September 21, 2016September 19, 2016 CBFV Purchase $24,514 +12.1%+10.6%+4.4%
February 5, 2016February 4, 2016 CBFV Purchase $10,000 −4.5%+12.7%+20.8%
May 6, 2015May 5, 2015 CBFV Purchase $10,000 +1.3%+12.0%+15.3%
February 5, 2015February 4, 2015 CBFV Purchase $19,740 −1.6%+13.4%+6.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Lacarte John J traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.